DOROTHY CLERICI: Open Payments
NPI 1205277654 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 89 payments from 13 companies in 2025. Trend: 2023 $1,902 · 2024 $1,517 · 2025 $1,807
Food & beverage: $1,807
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $303 |
| ABBVIE INC. | 15 | $289 |
| Axsome Therapeutics, Inc. | 8 | $228 |
| Otsuka America Pharmaceutical, Inc. | 13 | $224 |
| Vanda Pharmaceuticals Inc. | 8 | $210 |
| Teva Pharmaceuticals USA, Inc. | 12 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $106 |
| Neurocrine BioSciences, Inc. | 5 | $85 |
| Lundbeck LLC | 4 | $64 |
| Janssen Pharmaceuticals, Inc | 3 | $58 |
Products named: VRAYLAR, Auvelity, FANAPT, ARISTADA, LYBALVI, ABILIFY ASIMTUFII, REXULTI, CAPLYTA.
Industry payments across KY — which companies pay providers there.
